Ouyang Qianwen, Cui Yanru, Yang Shixin, Wei Wensong, Zhang Mingyue, Zeng Jie, Qu Fei
Department of Breast Surgery, The Third Hospital of Nanchang, Jiangxi, China Jiangxi Province Key Laboratory for Breast Diseases, Nanchang, Jiangxi 330009, People's Republic of China.
Department of Physiology, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, People's Republic of China.
Onco Targets Ther. 2020 Jun 4;13:5033-5046. doi: 10.2147/OTT.S241503. eCollection 2020.
The purpose of our research was to evaluate MT1JP in breast cancer.
For clinical purpose, tissues were collected, and a correlation analysis ofMT1JP and miRNA-214 gene expressions was conducted. Using an in vitro study, MDA-MB-231 and MCF-7 cell lines were used as research objects in our research. Colony, flow cytometry, TUNEL, transwell, adhesion and wound healing assay were used to discuss the biological activities of the cells. In an in vivo study, tumor weight and volume were measured, and cell apoptosis was measured by TUNEL assay. The relative mechanism's proteins were evaluated by Western blotting or immunohistochemistry assay.
Compared with adjacent tissues, MT1JP and miRNA-214 gene expressions were significantly different (P<0.001, respectively). By in vitro and in vivo studies, the biological activities of the cells were significantly decreased in MDA-MB-231 and MCF-7 cell lines with MT1JP overexpression. The relative mechanism was correlated with miRNA-214/RUNX3 axis.
The overexpression of MT1JP suppresses the biological activities of breast cancer cells by regulation miRNA-214/RUNX3 axis in vitro and vivo study.
我们研究的目的是评估MT1JP在乳腺癌中的作用。
出于临床目的,收集组织,并对MT1JP和miRNA - 214基因表达进行相关性分析。在体外研究中,我们使用MDA - MB - 231和MCF - 7细胞系作为研究对象。采用集落形成、流式细胞术、TUNEL、Transwell、黏附及伤口愈合实验来探讨细胞的生物学活性。在体内研究中,测量肿瘤重量和体积,并通过TUNEL实验检测细胞凋亡。通过蛋白质免疫印迹或免疫组织化学实验评估相关机制的蛋白质。
与癌旁组织相比,MT1JP和miRNA - 214基因表达存在显著差异(分别为P < 0.001)。通过体外和体内研究发现,MT1JP过表达的MDA - MB - 231和MCF - 7细胞系中细胞的生物学活性显著降低。相关机制与miRNA - 214/RUNX3轴有关。
在体外和体内研究中,MT1JP的过表达通过调控miRNA - 214/RUNX3轴抑制乳腺癌细胞的生物学活性。